Yazdanpanah Y - Search Results

1

Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.

Valerio L, Yazdanpanah Y, Poizot-Martin I, Rosenthal E, Marimoutou C, Gastaut JA, Tran A, Dellamonica P, Freedberg KA, Pradier C. Valerio L, et al. Among authors: yazdanpanah y. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):50-5. doi: 10.1097/QAI.0b013e318157b0da. J Acquir Immune Defic Syndr. 2008. PMID: 18156991 Free PMC article.

2

Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.

Bocket L, Yazdanpanah Y, Ajana F, Gerard Y, Viget N, Goffard A, Alcaraz I, Wattré P, Mouton Y. Bocket L, et al. Among authors: yazdanpanah y. J Antimicrob Chemother. 2004 Jan;53(1):89-94. doi: 10.1093/jac/dkh006. Epub 2003 Nov 25. J Antimicrob Chemother. 2004. PMID: 14645320 Clinical Trial.

3

Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness.

Bocket L, Cheret A, Deuffic-Burban S, Choisy P, Gerard Y, de la Tribonnière X, Viget N, Ajana F, Goffard A, Barin F, Mouton Y, Yazdanpanah Y. Bocket L, et al. Among authors: yazdanpanah y. Antivir Ther. 2005;10(2):247-54. Antivir Ther. 2005. PMID: 15865219

4

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

Losina E, Yazdanpanah Y, Deuffic-Burban S, Wang B, Wolf LL, Messou E, Gabillard D, Seyler C, Freedberg KA, Anglaret X. Losina E, et al. Among authors: yazdanpanah y. Antivir Ther. 2007;12(4):543-51. Antivir Ther. 2007. PMID: 17668563 Free PMC article.

5

Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling.

Deuffic-Burban S, Losina E, Wang B, Gabillard D, Messou E, Divi N, Freedberg KA, Anglaret X, Yazdanpanah Y. Deuffic-Burban S, et al. Among authors: yazdanpanah y. Eur J Epidemiol. 2007;22(10):737-44. doi: 10.1007/s10654-007-9175-5. Epub 2007 Sep 8. Eur J Epidemiol. 2007. PMID: 17828437 Free PMC article.

6

Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.

Bani-Sadr F, Miailhes P, Rosenthal E, Yazdanpanah Y, Boyer L, Zucman D, Cacoub P, Perronne C, Pol S, Carrat F; ANRS HC02 - Ribavic Study Team. Bani-Sadr F, et al. Among authors: yazdanpanah y. AIDS. 2008 Jun 19;22(10):1234-6. doi: 10.1097/QAD.0b013e3282fbd203. AIDS. 2008. PMID: 18525274 No abstract available.

7

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators. Walensky RP, et al. Ann Intern Med. 2009 Aug 4;151(3):157-66. doi: 10.7326/0003-4819-151-3-200908040-00138. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19620143 Free PMC article.

8

Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness.

Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KA; CEPAC-International Investigators. Kimmel AD, et al. Among authors: yazdanpanah y. J Acquir Immune Defic Syndr. 2010 Jul;54(3):258-68. doi: 10.1097/QAI.0b013e3181d0db97. J Acquir Immune Defic Syndr. 2010. PMID: 20404739 Free PMC article.

9

Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009.

Cacoub P, Halfon P, Rosenthal E, Bailly F, Sadr FB, Benhamou Y, Chevaliez S, Pawlotsky JM, Piroth L, Yazdanpanah Y, Pol S. Cacoub P, et al. Among authors: yazdanpanah y. J Hepatol. 2010 Aug;53(2):230-7. doi: 10.1016/j.jhep.2010.03.009. Epub 2010 Apr 27. J Hepatol. 2010. PMID: 20493575

10

CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials.

Yazdanpanah Y, Wolf LL, Anglaret X, Gabillard D, Walensky RP, Moh R, Danel C, Sloan CE, Losina E, Freedberg KA; CEPAC-International Investigators. Yazdanpanah Y, et al. Antivir Ther. 2010;15(3):351-61. doi: 10.3851/IMP1542. Antivir Ther. 2010. PMID: 20516555 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters